These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 35255350)

  • 1. Recent updates on development of protein-tyrosine phosphatase 1B inhibitors for treatment of diabetes, obesity and related disorders.
    Singh S; Singh Grewal A; Grover R; Sharma N; Chopra B; Kumar Dhingra A; Arora S; Redhu S; Lather V
    Bioorg Chem; 2022 Apr; 121():105626. PubMed ID: 35255350
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Status of research on natural protein tyrosine phosphatase 1B inhibitors as potential antidiabetic agents: Update.
    Liu Z; Gao H; Zhao Z; Huang M; Wang S; Zhan J
    Biomed Pharmacother; 2023 Jan; 157():113990. PubMed ID: 36459712
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent Advances in Protein Tyrosine Phosphatase 1B Targeted Drug Discovery for Type II Diabetes and Obesity.
    Maheshwari N; Karthikeyan C; Trivedi P; Moorthy NSHN
    Curr Drug Targets; 2018; 19(5):551-575. PubMed ID: 28228082
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protein tyrosine phosphatase 1B (PTP1B) function, structure, and inhibition strategies to develop antidiabetic drugs.
    Coronell-Tovar A; Pardo JP; Rodríguez-Romero A; Sosa-Peinado A; Vásquez-Bochm L; Cano-Sánchez P; Álvarez-Añorve LI; González-Andrade M
    FEBS Lett; 2024 Aug; 598(15):1811-1838. PubMed ID: 38724486
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potential Inhibitors of Protein Tyrosine Phosphatase (PTP1B) Enzyme: Promising Target for Type-II Diabetes Mellitus.
    Nandi S; Saxena M
    Curr Top Med Chem; 2020; 20(29):2692-2707. PubMed ID: 32888269
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Medicinal Aspects of PTP1B Inhibitors as Anti-Breast Cancer Agents: An Overview.
    Khator R; Biharee A; Bhatia N; Kulkarni S; Singh Y; Karthikeyan C; Jain AK; Thareja S
    Curr Med Chem; 2024; 31(34):5535-5549. PubMed ID: 37711015
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protein tyrosine phosphatase 1B in metabolic diseases and drug development.
    Delibegović M; Dall'Angelo S; Dekeryte R
    Nat Rev Endocrinol; 2024 Jun; 20(6):366-378. PubMed ID: 38519567
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protein tyrosine phosphatase 1B (PTP1B) and obesity.
    Cho H
    Vitam Horm; 2013; 91():405-24. PubMed ID: 23374726
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Role of protein tyrosine phosphatase 1B in the type 2 diabetes and obesity].
    Wang C; Wang L; Yang Z
    Yi Chuan; 2004 Nov; 26(6):941-6. PubMed ID: 15640130
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comprehensive review on the research progress of PTP1B inhibitors as antidiabetics.
    Agrawal N; Dhakrey P; Pathak S
    Chem Biol Drug Des; 2023 Oct; 102(4):921-938. PubMed ID: 37232059
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PTP1B inhibitors as potential therapeutics in the treatment of type 2 diabetes and obesity.
    Zhang ZY; Lee SY
    Expert Opin Investig Drugs; 2003 Feb; 12(2):223-33. PubMed ID: 12556216
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protein-tyrosine phosphatase 1B (PTP1B): a novel therapeutic target for type 2 diabetes mellitus, obesity and related states of insulin resistance.
    Goldstein BJ
    Curr Drug Targets Immune Endocr Metabol Disord; 2001 Nov; 1(3):265-75. PubMed ID: 12477292
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In silico structure-based design of a potent and selective small peptide inhibitor of protein tyrosine phosphatase 1B, a novel therapeutic target for obesity and type 2 diabetes mellitus: a computer modeling approach.
    Rao GS; Ramachandran MV; Bajaj JS
    J Biomol Struct Dyn; 2006 Feb; 23(4):377-84. PubMed ID: 16363874
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protein tyrosine phosphatase 1B inhibitors for diabetes.
    Johnson TO; Ermolieff J; Jirousek MR
    Nat Rev Drug Discov; 2002 Sep; 1(9):696-709. PubMed ID: 12209150
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent advances in PTP1B signaling in metabolism and cancer.
    Villamar-Cruz O; Loza-Mejía MA; Arias-Romero LE; Camacho-Arroyo I
    Biosci Rep; 2021 Nov; 41(11):. PubMed ID: 34726241
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel protein tyrosine phosphatase 1B inhibitors: interaction requirements for improved intracellular efficacy in type 2 diabetes mellitus and obesity control.
    Popov D
    Biochem Biophys Res Commun; 2011 Jul; 410(3):377-81. PubMed ID: 21683066
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Characterization and biological activity of new 4-oxo-1,4-dihydrocinnoline-based inhibitors of the tyrosine phosphatase PTP1B and TCPTP].
    Derkach KV; Zakharova IO; Bakhtyukov AA; Sorokoumov VN; Kuznetsova VS; Shpakov AO
    Biomed Khim; 2022 Dec; 68(6):427-436. PubMed ID: 36573409
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protein Tyrosine Phosphatase 1B Inhibitors: A Novel Therapeutic Strategy for the Management of type 2 Diabetes Mellitus.
    Prabhakar PK; Sivakumar PM
    Curr Pharm Des; 2019; 25(23):2526-2539. PubMed ID: 31333090
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent advances in the development of protein tyrosine phosphatase 1B inhibitors for Type 2 diabetes.
    Qian S; Zhang M; He Y; Wang W; Liu S
    Future Med Chem; 2016 Jul; 8(11):1239-58. PubMed ID: 27357615
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Toward a treatment of diabesity: In vitro and in vivo evaluation of uncharged bromophenol derivatives as a new series of PTP1B inhibitors.
    Li X; Xu Q; Li C; Luo J; Li X; Wang L; Jiang B; Shi D
    Eur J Med Chem; 2019 Mar; 166():178-185. PubMed ID: 30711829
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.